|
Mar 15
|
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
|
|
Mar 14
|
ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
|
|
Mar 12
|
ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023
|
|
Mar 12
|
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
|
|
Mar 11
|
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
|
|
Jan 16
|
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
|
|
Jan 8
|
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
|
|
Dec 19
|
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%
|
|
Oct 26
|
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
|
|
Oct 26
|
When Should You Buy ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
|
|
Aug 8
|
ClearPoint Neuro Reports Second Quarter 2023 Results
|
|
Apr 28
|
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
|